Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Nerv Ment Dis ; 185(10): 616-21, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9345251

RESUMO

The purpose of this study was to assess whether the presence and severity of psychiatric symptoms in stroke patients correlate with their length of stay (LOS) in a rehabilitation unit, with special emphasis on the role of negative symptoms (NS). Twenty-three stroke patients, consecutively recruited from the inpatient rehabilitation unit, were evaluated on admission with the Mini-Mental State Examination (MMSE), the Positive and Negative Symptom Scale (PANSS), the Hamilton Depression Rating Scale (HDRS), the Scale for Assessment of Negative Symptoms (SANS), and the Functional Independent Measure (FIM). NS scores significantly correlated with LOS, with SANS total score being the most informative, and the attentional impairment subscale the least. The group of patients with pronounced NS stayed in the hospital twice as long as patients with the score on the NS subscale of PANSS below 16. These two groups did not differ in their cognitive performance or in the positive symptom subscale of PANSS scores. Total FIM score on admission was lower and HDRS scores higher in patients with pronounced NS. However, these differences, unlike those of LOS, have not reached statistical significance. The presence and severity of NS in stroke patients are associated with a longer hospital stay. Identification and treatment of NS might lead to a faster discharge from rehabilitation unit.


Assuntos
Transtornos Cerebrovasculares/psicologia , Transtornos Cerebrovasculares/reabilitação , Tempo de Internação , Transtornos Mentais/diagnóstico , Escalas de Graduação Psiquiátrica/estatística & dados numéricos , Idoso , Análise de Variância , Transtornos Cerebrovasculares/diagnóstico , Feminino , Unidades Hospitalares , Hospitalização , Humanos , Masculino , Transtornos Mentais/psicologia , Pessoa de Meia-Idade , Esquizofrenia/classificação , Esquizofrenia/diagnóstico , Psicologia do Esquizofrênico , Índice de Gravidade de Doença
2.
Artigo em Inglês | MEDLINE | ID: mdl-9144102

RESUMO

This pilot study evaluated response of negative symptoms (NS) to methylphenidate in patients with dementia and relationships between NS, depression, and cognitive deficits in these patients. Consecutively admitted patients with NS and dementia--12 with dementia of Alzheimer's type and 15 with vascular dementia--were rated on severity of NS (SANS and PANSS-N scales), depressive symptoms (Ham-D), and cognitive impairment (MMSE) before and after treatment with methylphenidate. NS decreased significantly, and cognitive scores increased. A decrease in depression scores was nonsignificant after all variance attributable to NS was removed. NS, depression, and cognitive scores were not significantly intercorrelated. Results were similar for Alzheimer's and vascular dementia patients. Negative symptoms in dementia patients appear responsive to methylphenidate treatment. This effect may underlie putative changes in symptoms of depression observed by other researchers.


Assuntos
Doença de Alzheimer/psicologia , Estimulantes do Sistema Nervoso Central/uso terapêutico , Transtornos Cognitivos/psicologia , Transtorno Depressivo/tratamento farmacológico , Transtorno Depressivo/psicologia , Metilfenidato/uso terapêutico , Idoso , Estimulantes do Sistema Nervoso Central/administração & dosagem , Transtornos Cognitivos/diagnóstico , Transtorno Depressivo/diagnóstico , Feminino , Humanos , Masculino , Metilfenidato/administração & dosagem , Pessoa de Meia-Idade , Testes Neuropsicológicos , Esquizofrenia/tratamento farmacológico , Psicologia do Esquizofrênico
3.
J Clin Psychiatry ; 57(9): 402-6, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9746448

RESUMO

BACKGROUND: Anxiety disorders are among the most frequently diagnosed group of psychiatric disorders in the general population. Although anxiety disorders are often comorbid with depression and personality disorders, they rarely culminate in psychosis. METHOD: Having observed psychosis in the course of a severe panic attack, the authors prospectively identified four patients who experienced panic attacks with co-occurring psychosis. All met the DSM-IV criteria for panic disorder. Distinctive features of their clinical presentation, pharmacotherapy, and follow-up were recorded. RESULTS: Three patients had a history of panic disorder, and one had a history of generalized anxiety disorder. In all cases, psychosis (auditory hallucinations or delusions) originated in the course of a severe panic attack. Psychotic symptoms occurred only during panic attacks; however, these could occur up to 10 to 15 times a day. In all four patients, psychotic symptoms resolved after a brief time either spontaneously or with benzodiazepine/SSRI treatment. None of the patients required neuroleptic treatment. CONCLUSION: The cases suggest that psychosis may develop in the course of a severe panic attack in patients with panic disorder, as was reported previously for patients with obsessive-compulsive disorder and posttraumatic stress disorder. Distinguishing panic attacks with psychotic features from other psychotic disorders is clinically important since antipsychotic medication treatment for these psychotic symptoms is not indicated. Further research on the prevalence of psychotic symptoms in the anxiety disorders and the pathophysiology of this phenomenon is required to clarify the relationship between the anxiety disorders and psychosis.


Assuntos
Transtorno de Pânico/diagnóstico , Transtornos Psicóticos/diagnóstico , Adulto , Idade de Início , Percepção Auditiva , Benzodiazepinas/uso terapêutico , Comorbidade , Delusões/diagnóstico , Delusões/tratamento farmacológico , Delusões/epidemiologia , Diagnóstico Diferencial , Feminino , Flufenazina/uso terapêutico , Seguimentos , Alucinações/diagnóstico , Alucinações/tratamento farmacológico , Alucinações/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Transtorno de Pânico/tratamento farmacológico , Transtorno de Pânico/epidemiologia , Prognóstico , Transtornos Psicóticos/tratamento farmacológico , Transtornos Psicóticos/epidemiologia , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...